Clinical Trials Directory

Trials / Unknown

UnknownNCT05676372

Single-Cell Transcriptomics of the Peritoneal Microenvironment of Colorectal PC

The Role of the Peritoneal Microenvironment in the Pathogenesis of Colorectal Peritoneal Carcinomatosis: Single-cell Transcriptomics

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Single cell transcriptomics of CRC PC samples

Detailed description

Research methodology Before inclusion of patients, patients will be screened for the presence of hepatitis B, hepatitis C and HIV to ensure researcher safety. During cytoreductive surgery, a total of five samples of tumoral tissue will be acquired. Three of those samples will be utilized for ScRNASeq analysis, and two samples of a macrometastasis will be snap frozen and cryopreserved. Single-cell RNA-Sequencing analysis We will comprehensively catalog the stromal cell types in the microenvironment of colorectal cancer peritoneal metastases utilizing single-cell RNA sequencing (scRNAseq) on three samples (one of which should preferably originate from the omentum majus, to encompass milky spots) acquired from surgical waste material of patients undergoing cytoreductive surgery. After sample prelevation, samples will be transported as soon as possible while cooled and submerged in 10% PBS to the VIB facilities, where single cell suspensions will be made according to standard protocols. After cell selection by FACS (CD45+ and live/dead stain, to ensure a 50/50 mix of immune and stromal cells) and library prep, ScRNASeq will be performed. Single cell sequencing analysis will allow us to identify cell clusters that by usage of marker genes will be assigned to different known cell lineages. After annotation of data, a "landscape" of the composition of the tumor stroma will be acquired.

Conditions

Interventions

TypeNameDescription
PROCEDURECRC+HIPECSample prelevation of cytoreductive surgery

Timeline

Start date
2020-06-16
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2023-01-09
Last updated
2023-12-28

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05676372. Inclusion in this directory is not an endorsement.